MRKR ▲ +9.6% - Marker Therapeutics, Inc.
$MRKR - Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
19-OCT-2026 07:00 AM ET
Share this post
More filings for $MRKR
MRKR ▼ -4.3% - Marker Therapeutics, Inc.Sep 28, 2026MRKR ▼ -0.8% - Marker Therapeutics, Inc.Sep 22, 2026
View full $MRKR filing history →💬 Comments
Loading comments…
Leave a comment